Medication info
Igleks 0.3 mg (Empagliflozin)

Igleks 0.3 mg (Empagliflozin)

Prescription medicationTablet
Ingredient · strength
Enavogliflozin›0.3mg / 1 tablet
Manufacturer / importer
Hanol Bio Pharma Co., Ltd.
Appearance
Light orange, biconvex, triangular film-coated tablet
Packaging
30 tablets/box [(10 tablets/PTPX3)], 56 tablets/box [(14 tablets/PTPX4)], 30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202204355 · Approved 2022.12.05 · Insurance code 655605580

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
Type 2 diabetes mellitus: monotherapy and add-on combination therapy The recommended dose of this medicine is 0.3 mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents. This medicine may be taken with or without food. Safety and efficacy have not been established in patients with moderate or severe renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73m2. If the eGFR remains <60 mL/min/1.73m2, this medicine should be discontinued. No dose adjustment is necessary in patients with mild renal impairment.

Ingredients

Manufacturer
Hanol Bio Pharma Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Blood glucose control issues in patients with type 2 diabetes
View approved original text

This medication is used to help blood glucose control in patients with type 2 diabetes in conjunction with dietary and exercise therapy. It can effectively help to control blood glucose levels either alone or in combination with other medications.

Dosage and Administration

Adult dosage

Type 2 diabetes mellitus: monotherapy and add-on combination therapy The recommended dose of this medicine is 0.3 mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents. This medicine may be taken with or without food. Safety and efficacy have not been established in patients with moderate or severe renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73m2. If the eGFR remains <60 mL/min/1.73m2, this medicine should be discontinued. No dose adjustment is necessary in patients with mild renal impairment.

Precautions

This medication may not be suitable for certain patients. For example, patients with an allergy to the ingredients of this medication, or those with type 1 diabetes, severe renal or liver disease, should not take this medication. Caution should be exercised when administering this medication to patients with decreased fluid volume or poor kidney function. This medication may lower blood pressure or affect kidney function, so renal function and blood pressure status should be monitored periodically before and during treatment. The use of this medication is not recommended in patients with severe heart failure, and it should be used cautiously in patients with slightly impaired liver function. There is a risk of hypoglycemia when this medication is taken with insulin or insulin secretagogues, so attention should be paid to symptoms of hypoglycemia. Severe metabolic abnormalities called ketoacidosis may occur, so immediately consult a doctor if symptoms such as vomiting, abdominal pain, or difficulty breathing arise. The risk of urinary tract infections or genital infections may increase, so prompt treatment is necessary if symptoms of infection occur. This medication can cause dehydration, particularly in elderly patients or those taking diuretics, so adequate fluid intake and attention to signs of dehydration should be observed. It is recommended that women who are pregnant or breastfeeding do not use this medication, and safety in children and adolescents has not been established. Elderly patients should be administered this medication carefully under medical advice due to the higher risk of renal impairment and dehydration. Patients with severely impaired renal function should not take this medication, nor should patients with severe liver dysfunction. There is no specific antidote for overdose, so appropriate treatment should be administered based on symptoms. This medication should be kept out of reach of children, and it is advised not to transfer it to other containers.

Side effects

  • Dyspepsia
  • constipation
  • gastritis
  • upper abdominal pain
  • abdominal pain
  • diarrhea
  • dry mouth
  • enterocolitis
  • passage of blood in the stool
  • vaginal infection
Show 137 more
  • cystitis
  • pyelonephritis
  • anal abscess
  • folliculitis
  • athlete's foot
  • joint pain
  • back pain
  • intervertebral disc degeneration
  • spinal osteoarthritis
  • cervical stenosis
  • inguinal pain
  • musculoskeletal chest pain
  • spinal canal stenosis
  • contusion
  • ligament tear
  • ligament strain
  • wrist fracture
  • envenomation by arachnids
  • epicondylitis
  • muscle strain
  • headache
  • dizziness
  • paresthesia
  • friction urticaria
  • dyslipidemia
  • hyperlipidemia
  • benign prostatic hyperplasia
  • genital pruritus
  • cervical polyp
  • genital erythema
  • dysuria
  • nocturia
  • polyuria
  • cardiac hypertrophy
  • worsening condition
  • cough
  • respiratory distress
  • increased aspartate aminotransferase
  • increased alanine aminotransferase
  • headache
  • dizziness
  • pruritus
  • hypoglycemia
  • vulvar pruritus
  • frequent urination
  • nephrolithiasis
  • renal cyst
  • hepatic steatosis
  • toxic hepatitis
  • prostate cancer
  • speech disorder
  • hyperventilation
  • leukocytosis
  • anemia
  • bone marrow suppression
  • hypertension
  • orthostatic hypotension
  • insomnia
  • anxiety
  • subacute thyroiditis
  • chronic gastritis
  • colitis
  • COVID-19
  • nasopharyngitis
  • coronavirus infection
  • herpes zoster
  • vaginal infection
  • viral skin infection
  • joint pain
  • back pain
  • intervertebral disc herniation
  • scoliosis
  • ganglion cyst
  • epicondylitis
  • foot fracture
  • joint dislocation
  • skin laceration
  • tibial fracture
  • facial paralysis
  • sensory deficit
  • ingrown toenail
  • hives
  • hypoglycemia
  • hyperlipidemia
  • dysmenorrhea
  • vaginal bleeding
  • weakness
  • blood pressure decrease
  • blood pressure increase
  • falls
  • skin laceration
  • benign breast neoplasm
  • colorectal adenoma
  • gastrointestinal submucosal tumor
  • neuroma
  • varicose veins
  • angina
  • palpitations
  • dyspnea
  • lower abdominal pain
  • gastritis
  • pancreatic cyst
  • cholelithiasis
  • hair loss
  • rash
  • limb pain
  • calcification of muscles
  • flank pain
  • spinal osteoarthritis
  • dysuria
  • dysmenorrhea
  • vaginal bleeding
  • weakness
  • blood pressure decrease
  • blood pressure increase
  • falls
  • skin laceration
  • facial paralysis
  • headache
  • sensory deficit
  • ingrown toenail
  • hives
  • hypoglycemia
  • hyperlipidemia
  • benign prostatic hyperplasia
  • genital pruritus
  • membranous glomerulonephritis
  • cholelithiasis
  • unstable angina
  • myocarditis
  • chest pain
  • insomnia
  • benign breast neoplasm
  • colorectal adenoma
  • gastrointestinal submucosal tumor
  • neuroma
  • varicose veins

Not everyone experiences these, and they can vary from person to person.

Storage

Keep this medication in a tightly closed container to protect it from air and moisture. Additionally, store the medication at room temperature between 1°C and 30°C. This helps maintain the efficacy of the medication and allows for safe use.

Appearance and packaging

Appearance

Light orange, biconvex, triangular film-coated tablet

Package unit

30 tablets/box [(10 tablets/PTPX3)], 56 tablets/box [(14 tablets/PTPX4)], 30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.